300267 尔康制药
已收盘 09-02 15:00:00
资讯
新帖
简况
股市必读:尔康制药中报 - 第二季度单季净利润同比增长180.17%
证券之星 · 08-28
股市必读:尔康制药中报 - 第二季度单季净利润同比增长180.17%
图解尔康制药中报:第二季度单季净利润同比增长180.17%
证券之星 · 08-27
图解尔康制药中报:第二季度单季净利润同比增长180.17%
尔康制药:上半年归母净利润同比增长497.36%
新京报 · 08-27
尔康制药:上半年归母净利润同比增长497.36%
维生素概念盘中拉升,尔康制药涨8.69%
市场透视 · 07-30
维生素概念盘中拉升,尔康制药涨8.69%
超级真菌概念盘中拉升,尔康制药涨10.09%
市场透视 · 07-30
超级真菌概念盘中拉升,尔康制药涨10.09%
尔康制药(300267.SZ):二羟丙茶碱注射液获得药品注册证书
格隆汇 · 07-28
尔康制药(300267.SZ):二羟丙茶碱注射液获得药品注册证书
流感概念盘中拉升,尔康制药等3只股票涨停
市场透视 · 07-28
流感概念盘中拉升,尔康制药等3只股票涨停
异动快报:尔康制药(300267)7月28日9点37分触及涨停板
证券之星 · 07-28
异动快报:尔康制药(300267)7月28日9点37分触及涨停板
超级真菌概念盘中拉升,尔康制药涨11.45%
市场透视 · 07-25
超级真菌概念盘中拉升,尔康制药涨11.45%
尔康制药最新公告:孙公司尔康坦桑尼亚有限公司拟投资1000万美元建设综合制剂生产项目
证券之星 · 07-03
尔康制药最新公告:孙公司尔康坦桑尼亚有限公司拟投资1000万美元建设综合制剂生产项目
尔康制药上涨7.01%,报3.36元/股
金融界 · 07-01
尔康制药上涨7.01%,报3.36元/股
【尔康制药:维生素B6注射液通过仿制药一致性评价】尔康制药公告,公司维生素B6注射液1ml:100mg规格通过仿制药质量和疗效一致性评价,并于近日收到国家药品监督管理局核准签发的《药品补充申请批准通知书》。该药品主要用于维生素B6缺乏的预防和治疗,防治异烟肼中毒等。维生素B6注射液已列入《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》,属于甲类医保药物。截至公告披露日,已获批上市的国产维生素B6注射液批准文号中,通过或视同通过仿制药一致性评价的有9个(含公司)。
金融界 · 06-09
【尔康制药:维生素B6注射液通过仿制药一致性评价】尔康制药公告,公司维生素B6注射液1ml:100mg规格通过仿制药质量和疗效一致性评价,并于近日收到国家药品监督管理局核准签发的《药品补充申请批准通知书》。该药品主要用于维生素B6缺乏的预防和治疗,防治异烟肼中毒等。维生素B6注射液已列入《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》,属于甲类医保药物。截至公告披露日,已获批上市的国产维生素B6注射液批准文号中,通过或视同通过仿制药一致性评价的有9个(含公司)。
尔康制药:关于证券事务代表辞职的公告
新浪财经-鹰眼工作室 · 05-30
尔康制药:关于证券事务代表辞职的公告
【尔康制药等在杭州成立智能科技公司】 公开资料显示,近日,杭州朗德智能科技有限公司成立,法定代表人为周兆祎,注册资本为1000万元,经营范围包含:智能无人飞行器制造;智能无人飞行器销售;人工智能应用软件开发;人工智能硬件销售;智能机器人的研发等。股权数据显示,该公司由尔康制药旗下湖南冠禾科技有限公司、长沙悦安科技有限公司等共同持股。
金融界 · 04-28
【尔康制药等在杭州成立智能科技公司】 公开资料显示,近日,杭州朗德智能科技有限公司成立,法定代表人为周兆祎,注册资本为1000万元,经营范围包含:智能无人飞行器制造;智能无人飞行器销售;人工智能应用软件开发;人工智能硬件销售;智能机器人的研发等。股权数据显示,该公司由尔康制药旗下湖南冠禾科技有限公司、长沙悦安科技有限公司等共同持股。
尔康制药:2024年公司获得专利13项,其中发明专利2项,实用新型专利11项
证券之星 · 04-25
尔康制药:2024年公司获得专利13项,其中发明专利2项,实用新型专利11项
尔康制药:2024年公司研发投入金额为45,170,389.39元,占营业收入比例为3.96%
证券之星 · 04-25
尔康制药:2024年公司研发投入金额为45,170,389.39元,占营业收入比例为3.96%
4月24日尔康制药(300267)涨停分析:业绩高增、维生素涨价及NMN概念驱动
证券之星 · 04-24
4月24日尔康制药(300267)涨停分析:业绩高增、维生素涨价及NMN概念驱动
维生素D3价格猛蹿!板块应声爆发,尔康制药20CM涨停
格隆汇 · 04-24
维生素D3价格猛蹿!板块应声爆发,尔康制药20CM涨停
涨价刺激维生素概念股走强,尔康制药、兄弟科技涨停,卫信康涨超6%
格隆汇 · 04-24
涨价刺激维生素概念股走强,尔康制药、兄弟科技涨停,卫信康涨超6%
【化学制药板块震荡走强,河化股份、灵康药业涨停】化学制药板块震荡走强,河化股份、灵康药业涨停,尔康制药涨超10%,罗欣药业、益方生物纷纷冲高。
金融界 · 04-24
【化学制药板块震荡走强,河化股份、灵康药业涨停】化学制药板块震荡走强,河化股份、灵康药业涨停,尔康制药涨超10%,罗欣药业、益方生物纷纷冲高。
加载更多
公司概况
公司名称:
湖南尔康制药股份有限公司
所属行业:
医药制造业
上市日期:
2011-09-27
主营业务:
湖南尔康制药股份有限公司的主营业务是辅料、原料药、成品药、新能源材料的生产和销售。公司的主要产品是药用乙醇、药用甘油、改性淀粉、淀粉囊系列产品、蔗糖、复合辅料。公司拥有“国家药用辅料工程技术研究中心”“国家认定企业技术中心”以及“国家药品监督管理局药用辅料工程技术研究重点实验室”,还是国家药典委员会委员任职单位;公司积极参与《中国药典》药用辅料标准的修制订,参与《药用辅料红外光谱集》的编制,国家药典委授予公司14种药用辅料“品种监护人”资格;在国家药用辅料标准实施过程中,公司也成为国家药用辅料标准的积极参与者和推动者;公司持续开展注射用药用辅料产品质量提升研究,“注射用药用辅料关键技术开发及产业化”项目荣获湖南省科技进步奖二等奖;公司药用辅料淀粉胶囊等品种入选湖南省工业和信息化厅公布的湖南省生物医药产业链重点品种(第二批)名单。
发行价格:
17.97
{"stockData":{"symbol":"300267","market":"SZ","secType":"STK","nameCN":"尔康制药","latestPrice":3.83,"timestamp":1756796604000,"preClose":3.91,"halted":0,"volume":50266294,"delay":0,"changeRate":-0.0205,"floatShares":1422000000,"shares":2063000000,"eps":-0.1659,"marketStatus":"已收盘","change":-0.08,"latestTime":"09-02 15:00:00","open":3.92,"high":3.92,"low":3.78,"amount":193000000,"amplitude":0.0358,"askPrice":3.84,"askSize":2524,"bidPrice":3.83,"bidSize":5586,"shortable":0,"etf":0,"ttmEps":-0.1659,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756863000000},"marketStatusCode":5,"adr":0,"adjPreClose":3.91,"symbolType":"stock","openAndCloseTimeList":[[1756776600000,1756783800000],[1756789200000,1756796400000]],"highLimit":4.3,"lowLimit":3.52,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":2062604870,"isCdr":false,"pbRate":1.8,"roa":"--","roe":"0.85%","epsLYR":-0.181,"committee":0.223984,"marketValue":7900000000,"turnoverRate":0.0353,"status":1,"floatMarketCap":5448000000},"requestUrl":"/m/hq/s/300267","defaultTab":"news","newsList":[{"id":"2563063242","title":"股市必读:尔康制药中报 - 第二季度单季净利润同比增长180.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563063242","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563063242?lang=zh_cn&edition=full","pubTime":"2025-08-29 03:08","pubTimestamp":1756408091,"startTime":"0","endTime":"0","summary":"来自业绩披露要点:尔康制药2025年中报归母净利润同比增长497.36%,扣非净利润同比增长1357.97%。股本股东变化股东户数变动近日尔康制药披露,截至2025年6月30日公司股东户数为4.27万户,较3月31日增加1802.0户,增幅为4.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900001461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267"],"gpt_icon":0},{"id":"2562624724","title":"图解尔康制药中报:第二季度单季净利润同比增长180.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562624724","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562624724?lang=zh_cn&edition=full","pubTime":"2025-08-28 02:51","pubTimestamp":1756320718,"startTime":"0","endTime":"0","summary":"证券之星消息,尔康制药2025年中报显示,公司主营收入6.82亿元,同比上升9.74%;归母净利润3763.46万元,同比上升497.36%;扣非净利润3301.87万元,同比上升1357.97%;其中2025年第二季度,公司单季度主营收入3.28亿元,同比下降4.98%;单季度归母净利润952.21万元,同比上升180.17%;单季度扣非净利润830.94万元,同比上升48.19%;负债率12.56%,投资收益289.67万元,财务费用142.78万元,毛利率27.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800002139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267"],"gpt_icon":0},{"id":"2562674066","title":"尔康制药:上半年归母净利润同比增长497.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562674066","media":"新京报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562674066?lang=zh_cn&edition=full","pubTime":"2025-08-27 22:13","pubTimestamp":1756303980,"startTime":"0","endTime":"0","summary":"转自:贝壳财经新京报贝壳财经讯 8月27日晚间,尔康制药公告,2025年上半年营业收入6.82亿元,同比增长9.74%,归母净利润3763.46万元,同比增长497.36%。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-08-27/doc-infnmvkz8935611.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-08-27/doc-infnmvkz8935611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300267"],"gpt_icon":0},{"id":"2555109936","title":"维生素概念盘中拉升,尔康制药涨8.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555109936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555109936?lang=zh_cn&edition=full","pubTime":"2025-07-30 11:15","pubTimestamp":1753845325,"startTime":"0","endTime":"0","summary":"07月30日,维生素概念盘中拉升,截至11点15分,维生素概念整体指数上涨1.02%,报1783.160点。从个股上来看,该概念的成分股中,尔康制药涨8.69%,梅花生物、浙江医药、新 和 成涨幅居前。从资金上来看,截止发稿,维生素概念主力净流入为-1.59亿,其中华润三九受到资金热捧,主力净流入5509.24万;拉长时间线来看,该板块近20日主力资金净流入-18.33亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073011152594c2e836&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073011152594c2e836&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300267","BK0077","BK0191","600216","BK0028","BK0188","600873","BK0239"],"gpt_icon":0},{"id":"2555333096","title":"超级真菌概念盘中拉升,尔康制药涨10.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555333096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555333096?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:22","pubTimestamp":1753842140,"startTime":"0","endTime":"0","summary":"07月30日,超级真菌概念盘中拉升,截至10点22分,超级真菌概念整体指数上涨1.00%,报891.820点。从个股上来看,该概念的成分股中,尔康制药涨10.09%,科伦药业、国药现代、白云山涨幅居前。从资金上来看,截止发稿,超级真菌概念主力净流入为-4456.62万,其中华海药业受到资金热捧,主力净流入2823.37万;拉长时间线来看,该板块近20日主力资金净流入-11.26亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730102220a6c8c4f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730102220a6c8c4f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0132","600420","BK0077","600521","BK0082","BK0028","BK0010","300267","BK0020"],"gpt_icon":0},{"id":"2554271247","title":"尔康制药(300267.SZ):二羟丙茶碱注射液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2554271247","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554271247?lang=zh_cn&edition=full","pubTime":"2025-07-28 17:39","pubTimestamp":1753695564,"startTime":"0","endTime":"0","summary":"格隆汇7月28日丨尔康制药(300267.SZ)公布,公司于近日收到国家药品监督管理局签发的《药品注册证书》,公司二羟丙茶碱注射液获批注册。二羟丙茶碱属于平滑肌松弛药,有扩张支气管和冠状动脉的作用,并有利尿作用,在胃液中稳定,平喘作用与氨茶碱相似,尤适用于伴有心动过速的患者。适用于支气管哮喘、喘息型支气管炎、阻塞性肺气肿等以缓解喘息症状,也用于心源性肺水肿引起的哮喘。二羟丙茶碱注射液属于《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》乙类品种。公司该药品是按新的化学药品注册分类获批上市,获批后视同通过一致性评价。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/28173952025045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","300267","BK0077","BK0028"],"gpt_icon":0},{"id":"2554742515","title":"流感概念盘中拉升,尔康制药等3只股票涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2554742515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554742515?lang=zh_cn&edition=full","pubTime":"2025-07-28 09:45","pubTimestamp":1753667150,"startTime":"0","endTime":"0","summary":"07月28日,流感概念盘中拉升,截至09点45分,流感概念整体指数上涨1.12%,报1097.860点。从个股上来看,该概念的成分股中,科华生物涨幅超过10%,尔康制药等3只股票涨停,丰原药业、联环药业等6只股涨幅超过5%。从资金上来看,截止发稿,流感概念主力净流入为3.69亿,其中尔康制药受到资金热捧,主力净流入1.39亿;拉长时间线来看,该板块近20日主力资金净流入-76.26亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728094550a6c4e20a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728094550a6c4e20a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0077","BK0028","300267","600513"],"gpt_icon":0},{"id":"2554744801","title":"异动快报:尔康制药(300267)7月28日9点37分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2554744801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554744801?lang=zh_cn&edition=full","pubTime":"2025-07-28 09:40","pubTimestamp":1753666855,"startTime":"0","endTime":"0","summary":"证券之星7月28日盘中消息,9点37分尔康制药触及涨停板。目前价格4.51,上涨19.95%。其所属行业化学制药目前上涨。领涨股为尔康制药。该股为化学原料药,中药,医药概念热股,当日化学原料药概念上涨1.04%,中药概念上涨0.91%,医药概念上涨0.9%。7月25日的资金流向数据方面,主力资金净流入2674.37万元,占总成交额2.81%,游资资金净流入2214.27万元,占总成交额2.32%,散户资金净流出4888.63万元,占总成交额5.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072800004285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","300267","BK0239"],"gpt_icon":0},{"id":"2554732608","title":"超级真菌概念盘中拉升,尔康制药涨11.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554732608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554732608?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:43","pubTimestamp":1753407813,"startTime":"0","endTime":"0","summary":"07月25日,超级真菌概念盘中拉升,截至09点43分,超级真菌概念整体指数上涨1.16%,报870.420点。从个股上来看,该概念的成分股中,尔康制药涨11.45%,上海凯宝、联环药业、普洛药业涨幅居前。从资金上来看,截止发稿,超级真菌概念主力净流入为-8430.48万,其中联环药业受到资金热捧,主力净流入1603.67万;拉长时间线来看,该板块近20日主力资金净流入-12.45亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725094333971d31de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725094333971d31de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0239","300267","BK0028","600513"],"gpt_icon":0},{"id":"2548801137","title":"尔康制药最新公告:孙公司尔康坦桑尼亚有限公司拟投资1000万美元建设综合制剂生产项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2548801137","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548801137?lang=zh_cn&edition=full","pubTime":"2025-07-03 20:00","pubTimestamp":1751544024,"startTime":"0","endTime":"0","summary":"尔康制药(300267.SZ)公告称,公司第五届董事会第十四次会议审议通过了《关于孙公司尔康坦桑尼亚有限公司建设综合制剂生产项目的议案》。根据该议案,尔康坦桑尼亚有限公司拟使用自筹资金1000万美元投资建设综合制剂生产项目。该议案已经公司第五届董事会第四次战略与发展委员会会议审议通过,并同意提交董事会审议。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300034173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0077","300267"],"gpt_icon":0},{"id":"2548236270","title":"尔康制药上涨7.01%,报3.36元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548236270","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548236270?lang=zh_cn&edition=full","pubTime":"2025-07-01 10:48","pubTimestamp":1751338100,"startTime":"0","endTime":"0","summary":"7月1日,尔康制药盘中上涨7.01%,截至10:48,报3.36元/股,成交1.62亿元,换手率3.53%,总市值69.3亿元。截至9月30日,尔康制药股东户数4.36万,人均流通股3.27万股。2024年1月-9月,尔康制药实现营业收入8.54亿元,同比减少40.89%;归属净利润-2546.73万元,同比减少163.55%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/01104851403001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300267","BK0239","BK0077","BK0028"],"gpt_icon":0},{"id":"2542801416","title":"【尔康制药:维生素B6注射液通过仿制药一致性评价】尔康制药公告,公司维生素B6注射液1ml:100mg规格通过仿制药质量和疗效一致性评价,并于近日收到国家药品监督管理局核准签发的《药品补充申请批准通知书》。该药品主要用于维生素B6缺乏的预防和治疗,防治异烟肼中毒等。维生素B6注射液已列入《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》,属于甲类医保药物。截至公告披露日,已获批上市的国产维生素B6注射液批准文号中,通过或视同通过仿制药一致性评价的有9个(含公司)。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542801416","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542801416?lang=zh_cn&edition=full","pubTime":"2025-06-09 16:41","pubTimestamp":1749458478,"startTime":"0","endTime":"0","summary":"尔康制药公告,公司维生素B6注射液1ml:100mg规格通过仿制药质量和疗效一致性评价,并于近日收到国家药品监督管理局核准签发的《药品补充申请批准通知书》。该药品主要用于维生素B6缺乏的预防和治疗,防治异烟肼中毒等。维生素B6注射液已列入《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》,属于甲类医保药物。截至公告披露日,已获批上市的国产维生素B6注射液批准文号中,通过或视同通过仿制药一致性评价的有9个(含公司)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/09164150948274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","300267","BK0239","BK0077"],"gpt_icon":0},{"id":"2539479942","title":"尔康制药:关于证券事务代表辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2539479942","media":"新浪财经-鹰眼工作室","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539479942?lang=zh_cn&edition=full","pubTime":"2025-05-30 17:20","pubTimestamp":1748596800,"startTime":"0","endTime":"0","summary":"湖南尔康制药股份有限公司关于证券事务代表辞职的公告本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏湖南尔康制药股份有限公司于近日收到公司证券事务代表范艺女士的书面辞职报告,范艺女士因个人原因申请辞去公司证券事务代表职务,辞职后将不再担任公司及子公司任何职务。上述辞职报告自送达公司董事会之日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-05-30/doc-ineyitny8658426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","300267","161027","BK0239","BK0028"],"gpt_icon":0},{"id":"2530419613","title":"【尔康制药等在杭州成立智能科技公司】 公开资料显示,近日,杭州朗德智能科技有限公司成立,法定代表人为周兆祎,注册资本为1000万元,经营范围包含:智能无人飞行器制造;智能无人飞行器销售;人工智能应用软件开发;人工智能硬件销售;智能机器人的研发等。股权数据显示,该公司由尔康制药旗下湖南冠禾科技有限公司、长沙悦安科技有限公司等共同持股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530419613","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530419613?lang=zh_cn&edition=full","pubTime":"2025-04-28 12:23","pubTimestamp":1745814212,"startTime":"0","endTime":"0","summary":"公开资料显示,近日,杭州朗德智能科技有限公司成立,法定代表人为周兆祎,注册资本为1000万元,经营范围包含:智能无人飞行器制造;智能无人飞行器销售;人工智能应用软件开发;人工智能硬件销售;智能机器人的研发等。股权数据显示,该公司由尔康制药旗下湖南冠禾科技有限公司、长沙悦安科技有限公司等共同持股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/28122349941965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300267","BK0077","BK0239","161631","BK0028"],"gpt_icon":0},{"id":"2530138053","title":"尔康制药:2024年公司获得专利13项,其中发明专利2项,实用新型专利11项","url":"https://stock-news.laohu8.com/highlight/detail?id=2530138053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530138053?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:52","pubTimestamp":1745585554,"startTime":"0","endTime":"0","summary":"证券之星消息,尔康制药04月24日在投资者关系平台上答复投资者关心的问题。公司《2024年年度报告》中披露的专利情况如下:2024年公司获得专利13项,其中发明专利2项,实用新型专利11项;截至2024年12月31日,公司拥有214项授权专利,包括203项国内专利、11项国外专利。2024年公司研发投入金额为45,170,389.39元,研发项目及进展也已在年度报告中进行具体说明。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500034567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","300267","BK0239"],"gpt_icon":0},{"id":"2530138783","title":"尔康制药:2024年公司研发投入金额为45,170,389.39元,占营业收入比例为3.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530138783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530138783?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:52","pubTimestamp":1745585541,"startTime":"0","endTime":"0","summary":"证券之星消息,尔康制药(300267)04月24日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司每年的研发费用过低,请贵公司加大研发投入尔康制药回复:您好,感谢您的关注和建议。2024年公司研发投入金额为45,170,389.39元,占营业收入比例为3.96%。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500034561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267"],"gpt_icon":0},{"id":"2529626104","title":"4月24日尔康制药(300267)涨停分析:业绩高增、维生素涨价及NMN概念驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2529626104","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529626104?lang=zh_cn&edition=full","pubTime":"2025-04-24 15:33","pubTimestamp":1745479989,"startTime":"0","endTime":"0","summary":"证券之星消息,尔康制药4月24日涨停收盘,收盘价3.12元。该股于9点45分涨停,未打开涨停,截止收盘封单资金为1.39亿元,占其流通市值3.12%。4月24日的资金流向数据方面,主力资金净流入1.28亿元,占总成交额33.53%,游资资金净流出6963.01万元,占总成交额18.29%,散户资金净流出5805.79万元,占总成交额15.25%。近5日资金流向一览见下表:该股为化学原料药,医药,中药概念热股,当日化学原料药概念上涨1.55%,医药概念上涨0.62%,中药概念上涨0.38%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400020853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300267","BK0077"],"gpt_icon":0},{"id":"2529640913","title":"维生素D3价格猛蹿!板块应声爆发,尔康制药20CM涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2529640913","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529640913?lang=zh_cn&edition=full","pubTime":"2025-04-24 14:12","pubTimestamp":1745475148,"startTime":"0","endTime":"0","summary":"机构:预计国内维生素份额还将持续提升","market":"sg","thumbnail":"https://img3.gelonghui.com/14344-867fbd54-14cf-4ad5-aa1a-e1d5e9e3e0e3.jpg?guru_height=717&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/14344-867fbd54-14cf-4ad5-aa1a-e1d5e9e3e0e3.jpg?guru_height=717&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2089748","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["002365","300267","BK0201","BK0010","BK0197","BK0070","BK0191","603102","BK0239","BK0188","BK0077","000953","LU0405327494.USD","603676","BK0187","BK0086","BK0226","BK0028","BK0186","BK0071","LU0405327148.USD","002001","002562","BK0066","BK0004"],"gpt_icon":0},{"id":"2529616161","title":"涨价刺激维生素概念股走强,尔康制药、兄弟科技涨停,卫信康涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529616161","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529616161?lang=zh_cn&edition=full","pubTime":"2025-04-24 10:23","pubTimestamp":1745461419,"startTime":"0","endTime":"0","summary":"格隆汇4月24日|A股市场维生素概念股表现强势,其中,尔康制药20CM涨停,兄弟科技10CM涨停,新赣江、卫信康涨超6%,花园生物涨超4%,能特科技、百合股份、民生健康涨超3%。消息面上,台州海盛将饲料级维生素D3国内报价上调至600元/公斤;4月国内主要厂商已集体停报,欧洲市场库存告急。另外,尔康制药日前公布业绩显示,2025年一季度营业收入3.54亿元,同比增长28.19%;归属于上市公司股东的净利润2811.26万元,同比增长868.91%。\n\n\r\n 责任编辑:栎树","market":"us","thumbnail":"http://imgcloud.jrjimg.cn/2025/04/cms_20250424102339227.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2025/04/cms_20250424102339227.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.jrj.com.cn/2025/04/24102349816827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","BK0077","BK0201","BK0191","300267","BK0186","BK0239","002562","603676"],"gpt_icon":0},{"id":"2529618390","title":"【化学制药板块震荡走强,河化股份、灵康药业涨停】化学制药板块震荡走强,河化股份、灵康药业涨停,尔康制药涨超10%,罗欣药业、益方生物纷纷冲高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529618390","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529618390?lang=zh_cn&edition=full","pubTime":"2025-04-24 09:44","pubTimestamp":1745459060,"startTime":"0","endTime":"0","summary":"化学制药板块震荡走强,河化股份、灵康药业涨停,尔康制药涨超10%,罗欣药业、益方生物纷纷冲高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/24094449815496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0066","BK0001","BK0056","300267","688382","000953","08058","BK0077","BK1574","BK0201","BK0010","BK0033","01477","BK0028","603669","002793","BK0132","BK1191","BK0239","BK0071","BK0004"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1756801457214,"stockEarnings":[{"period":"1week","weight":-0.0417},{"period":"1month","weight":-0.0778},{"period":"3month","weight":0.1777},{"period":"6month","weight":0.4375},{"period":"1year","weight":0.7301},{"period":"ytd","weight":0.4065}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":0.0886},{"period":"3month","weight":0.1528},{"period":"6month","weight":0.1597},{"period":"1year","weight":0.3636},{"period":"ytd","weight":0.1563}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南尔康制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"42746人(较上一季度增加4.40%)","perCapita":"33275股","listingDate":"2011-09-27","address":"湖南省长沙市浏阳市经济开发区康平路167号","registeredCapital":"206260万元","survey":" 湖南尔康制药股份有限公司的主营业务是辅料、原料药、成品药、新能源材料的生产和销售。公司的主要产品是药用乙醇、药用甘油、改性淀粉、淀粉囊系列产品、蔗糖、复合辅料。公司拥有“国家药用辅料工程技术研究中心”“国家认定企业技术中心”以及“国家药品监督管理局药用辅料工程技术研究重点实验室”,还是国家药典委员会委员任职单位;公司积极参与《中国药典》药用辅料标准的修制订,参与《药用辅料红外光谱集》的编制,国家药典委授予公司14种药用辅料“品种监护人”资格;在国家药用辅料标准实施过程中,公司也成为国家药用辅料标准的积极参与者和推动者;公司持续开展注射用药用辅料产品质量提升研究,“注射用药用辅料关键技术开发及产业化”项目荣获湖南省科技进步奖二等奖;公司药用辅料淀粉胶囊等品种入选湖南省工业和信息化厅公布的湖南省生物医药产业链重点品种(第二批)名单。","listedPrice":17.97},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"尔康制药(300267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供尔康制药(300267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"尔康制药,300267,尔康制药股票,尔康制药股票老虎,尔康制药股票老虎国际,尔康制药行情,尔康制药股票行情,尔康制药股价,尔康制药股市,尔康制药股票价格,尔康制药股票交易,尔康制药股票购买,尔康制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"尔康制药(300267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供尔康制药(300267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}